Status: Ongoing

Server time: 22.11.2024 21:13

Tender card #RVO/8134/2021
"Lieky RVO/1834/2021 v rozsahu IMMUNOPREPARÁTA, CYTOSTATIKÁ, ANTIHORMÓNA pre potreby FNsP F. D. Roosevelta Banská Bystrica

Information

ID of tender
16499
Name of content of tender
"Lieky RVO/1834/2021 v rozsahu IMMUNOPREPARÁTA, CYTOSTATIKÁ, ANTIHORMÓNA pre potreby FNsP F. D. Roosevelta Banská Bystrica
Tender ref. no.
RVO/8134/2021
Public tender journal ref. no.
č 11/2022 2457-MST z 18.01.2022
EU journal ref. no.
2022/S 011-023132 dňa 17.01.2022
Type of tender
Nadlimitná zákazka
Type of public tender
Verejná súťaž podľa § 66 (7)
Type of procurement
Goods
Estimated value
10 602 269,2196 EUR
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
33652100-6 - Antineoplastic agents
33641300-8 - Sex hormones and modulators of the genital system
Tender split into parts
Yes
Centralised tender
No
NUTS
SK - Slovenská republika
Brief description of tender or procurement

Predmet zákazky je rozdelený na častí. Uchádzačovi sa umožňuje predložiť ponuku na celý predmet zákazky - na všetkých 77 častí, alebo len na jednu časť predmetu zákazky alebo na viacero častí predmetu zákazky, špecifikovaných v bode „ C – Opis predmetu zákazky „ týchto súťažných podkladov.

For evaluation the price is determined

including VAT

Schedule

Lehota na predkladanie ponúk
21.02.2022 09:00:00
Planned opening of bids
21.02.2022 13:00:00

Public Promoter

Subject's name
Fakultná nemocnica s poliklinikou F.D. Roosevelta Banská Bystrica
Address
Nám. L.Svobodu 1
Banská Bystrica
975 17, Slovak republic
Process supervisor
Ing Katarína Husíková
khusikova@nspbb.sk
+421 484413240

Documents

Časť č. 1

Status
Ongoing
Predicted value not including VAT
397 406,7000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 2

Status
Ongoing
Predicted value not including VAT
1 849,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 3

Status
Ongoing
Predicted value not including VAT
13 970,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 4

Status
Ongoing
Predicted value not including VAT
3 621,6400 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 5

Status
Ongoing
Predicted value not including VAT
258 586,9096 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 6

Status
Ongoing
Predicted value not including VAT
289 292,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 7

Status
Ongoing
Predicted value not including VAT
271 410,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 8

Status
Ongoing
Predicted value not including VAT
197 819,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 9

Status
Ongoing
Predicted value not including VAT
75 676,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 10

Status
Ongoing
Predicted value not including VAT
22 540,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 11

Status
Ongoing
Predicted value not including VAT
6 063,2200 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 12

Status
Ongoing
Predicted value not including VAT
15 054,8800 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 13

Status
Ongoing
Predicted value not including VAT
65 654,6000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 14

Status
Ongoing
Predicted value not including VAT
135 192,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 15

Status
Ongoing
Predicted value not including VAT
692,1600 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 16

Status
Ongoing
Predicted value not including VAT
52 080,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 17

Status
Ongoing
Predicted value not including VAT
626 666,0400 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 18

Status
Ongoing
Predicted value not including VAT
71 112,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 19

Status
Ongoing
Predicted value not including VAT
22 153,6000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 20

Status
Ongoing
Predicted value not including VAT
31 755,3600 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 21

Status
Ongoing
Predicted value not including VAT
810,3000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 22

Status
Ongoing
Predicted value not including VAT
16 389,2400 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 23

Status
Ongoing
Predicted value not including VAT
172,4000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 24

Status
Ongoing
Predicted value not including VAT
1 844,9400 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 25

Status
Ongoing
Predicted value not including VAT
101 233,9200 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 26

Status
Ongoing
Predicted value not including VAT
287 045,5464 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 27

Status
Ongoing
Predicted value not including VAT
36 616,8000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 28

Status
Ongoing
Predicted value not including VAT
1 430,0800 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 29

Status
Ongoing
Predicted value not including VAT
265,3000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 30

Status
Ongoing
Predicted value not including VAT
132,3000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 31

Status
Ongoing
Predicted value not including VAT
222 788,8000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 32

Status
Ongoing
Predicted value not including VAT
59 090,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 33

Status
Ongoing
Predicted value not including VAT
401 217,4200 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 34

Status
Ongoing
Predicted value not including VAT
223 366,8200 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 35

Status
Ongoing
Predicted value not including VAT
4 705 665,4400 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 36

Status
Ongoing
Predicted value not including VAT
31 760,6000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 37

Status
Ongoing
Predicted value not including VAT
93 543,1000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 38

Status
Ongoing
Predicted value not including VAT
23 986,6770 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 39

Status
Ongoing
Predicted value not including VAT
215 252,9800 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 40

Status
Ongoing
Predicted value not including VAT
9 167,7600 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 41

Status
Ongoing
Predicted value not including VAT
2 061,3200 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 42

Status
Ongoing
Predicted value not including VAT
19 377,8000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 43

Status
Ongoing
Predicted value not including VAT
20 564,3600 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 44

Status
Ongoing
Predicted value not including VAT
17 052,3600 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 45

Status
Ongoing
Predicted value not including VAT
39 384,3060 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 46

Status
Ongoing
Predicted value not including VAT
2 541,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 47

Status
Ongoing
Predicted value not including VAT
6 530,8400 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 48

Status
Ongoing
Predicted value not including VAT
8 134,2800 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Outcome of tender
Framework Agreement

Časť č. 49

Status
Ongoing
Predicted value not including VAT
16 978,8896 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

časť č. 50

Status
Ongoing
Predicted value not including VAT
43 849,1200 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 51

Status
Ongoing
Predicted value not including VAT
58 984,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 52

Status
Ongoing
Predicted value not including VAT
2 138,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 53

Status
Ongoing
Predicted value not including VAT
9,3000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 54

Status
Ongoing
Predicted value not including VAT
18 486,8000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 55

Status
Ongoing
Predicted value not including VAT
358 581,9600 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 56

Status
Ongoing
Predicted value not including VAT
118 113,7400 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 57

Status
Ongoing
Predicted value not including VAT
23 631,8400 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 58

Status
Ongoing
Predicted value not including VAT
533 336,4000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 59

Status
Ongoing
Predicted value not including VAT
83 232,6000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 60

Status
Ongoing
Predicted value not including VAT
31 262,7000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 61

Status
Ongoing
Predicted value not including VAT
30 721,9200 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 62

Status
Ongoing
Predicted value not including VAT
32 432,4000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 63

Status
Ongoing
Predicted value not including VAT
2 714,9600 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 64

Status
Ongoing
Predicted value not including VAT
38,4400 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 65

Status
Ongoing
Predicted value not including VAT
6 072,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 66

Status
Ongoing
Predicted value not including VAT
58 509,0910 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 67

Status
Ongoing
Predicted value not including VAT
14 605,2200 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 68

Status
Ongoing
Predicted value not including VAT
7 697,2000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 69

Status
Ongoing
Predicted value not including VAT
245,5600 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
One-off Contract

Časť č. 70

Status
Ongoing
Predicted value not including VAT
270,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 71

Status
Ongoing
Predicted value not including VAT
1 991,5800 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 72

Status
Ongoing
Predicted value not including VAT
12 758,5600 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 73

Status
Ongoing
Predicted value not including VAT
12 684,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 74

Status
Ongoing
Predicted value not including VAT
21 959,2800 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33641300-8 - Sex hormones and modulators of the genital system
Outcome of tender
Framework Agreement

Časť č. 75

Status
Ongoing
Predicted value not including VAT
94,0800 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33641300-8 - Sex hormones and modulators of the genital system
Outcome of tender
Framework Agreement

Časť č. 76

Status
Ongoing
Predicted value not including VAT
90,7200 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33641300-8 - Sex hormones and modulators of the genital system
Outcome of tender
Framework Agreement

Časť č. 77

Status
Ongoing
Predicted value not including VAT
4 757,0600 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33641300-8 - Sex hormones and modulators of the genital system
Outcome of tender
Framework Agreement